Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants ...

Labels of all extended-release stimulants indicated for ADHD -- including certain formulations of amphetamine and ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants to treat ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Researchers reviewing nearly 300 top-tier ADHD drug trials found that half skipped the rigorous, expert-led evaluations ...

Children younger than 6 years of age who are prescribed extended-release stimulants for attention-deficit hyperactivity disorder (ADHD) may experience ...

Collegium's new ADHD drugs may allow the company to grow revenues faster and pay off debt faster. Click here to find out why ...

The FDA now requires updated labeling for all extended-release stimulant medications used to treat attention deficit hyperactivity disorder, warning of increased risk of weight loss and other side ...

A nationwide Finnish study shows that children with ADHD stay on medication for over three years on average. Yet, controlled safety data for these medications in children exists for only one year, ...

People with ADHD often struggle with executive function, which Didier describes as “your brain’s GPS” for navigating your day ...

As ADHD medication use has surged in Sweden over the past decades, evidence is needed on whether the benefit of the ...